Cancer Outcomes Conference 2012

The Cancer Outcomes Conference took place on 14th and 15th June 2012 at the Hilton Birmingham Metropole.

See the full Cancer Outcomes Conference final programme

See the conference posters

The 2013 conference will take place on the 13th and 14th June. 

Conference presentations

To download the presentation, click on the session title. If the title does not have a link, it is because the presentation is unavailable. 

Day one – 14th June

The evolution of national cancer intelligence

• The evolution of the Network - Chris Carrigan, Head of the National Cancer Intelligence Network
• Using data to change clinical practice - Mick Peake, Clinical Lead, National Cancer Intelligence Network
• Is data really benefiting patients? - Ciaran Devane, Chief Executive, Macmillan Cancer Support

AM Parallel sessions

Early diagnosis, screening and prevention

• Chairs introduction - Sara Hiom, Director of information, Cancer Research UK
• Routes to diagnosis: the importance of emergency presentations - Dr Sean McPhail, National Cancer Intelligence Network
• Monitoring emergency presentations using Admitted Patient Care data - Jon Shelton, National Cancer Intelligence Network
• Public attitudes and cancer beliefs in Norther Ireland: a study of the International Cancer Benchmarking Partnership - Dr Anna Gavin, Northern Ireland Cancer Registry, Queens University Belfast

Patient experience and reported outcomes

• Chair’s introduction - Dr David Cromwell, Senior Lecturer, London School of Hygiene and Tropical Medicine 
• Patient-reported outcomes of colorectal cancer surgery: a systematic review of outcome measures - Robert Whistance, University of Bristol
• Variations in satisfaction with involvement in decisions about cancer treatment: analysis of the National Cancer Patient Experience Survey 2010 - Dr Anas El Turabi, Cambridge Centre for Health Services Research
• Which outcomes are important to patients and surgeons? Core disclosure prior to oesophageal cancer surgery - Natalie Blencowe, University of Bristol

Epidemiology

• Chair's introduction - Professor Henrik MØller, Professor of Cancer Epidemiology, Kings College London
• Second primary cancer risk after breast colorectal and prostate cancers: results from long-term follow-up of cancer registry patients in Scotland - Aishah Coyte, University of Glasgow
• Colorectal cancer risk in patients undergoing colonoscopic polypectomy: a large population-based study - Helen Coleman, Queen's University Belfast
• Enabling longitudinal follow up of cancer outcomes in the UK Biobank; a pilot linkage to the National Cancer Data Repository - Rachael Brannan, National Cancer Intelligence Network

Cancer Audit

• Chair's introduction - Dr Mick Peake, Clinical Lead, National Cancer Intelligence Netowork
• Improvements in 1-year survival rates in lung cancer: a networks experience of undertaking a systematic review of information to inform cause and effect - She Lok, Mount Vernon Cancer Network Lung Site Specific Group
• On-line portal for the validation of BCCOM data: results from Year 1 - Catherine Lagord, West Midlands Cancer Intelligence Unit
• Lung cancer data in the National Cancer Data Repository; Hospital Episodes Statistics and National Lung Cancer Audit datasets: a comparison of case ascertainment and the recording of lung cancer histology and treatment - Sharma Riaz, King's College London

Using clinical information to improve services and outcomes

• Chair's introduction - Dr Mark Davies, Medical Director, NHS Information Centre
• Information to improve cancer screening services - Professor Julietta Patnick CBE, Director, NHS Cancer Screening Programmes
• Information to improve clinical services - Di Riley, Associate Director, Clinical Outcomes Programme, National Cancer Intelligence Network
• Information to improve public health - Gill Lawrence, Director, West Midlands Cancer Intelligence Unit

PM Parallel sessions

Staging

• Chair's introduction - Dr Brian Rous, Chair, National Cancer Intelligence Network National Staging Panel
• Measuring the quality of registry staging data - Dr Sally Vernon, Eastern Cancer Registration and Information Centre
• An ontology-based System for Information Extraction; Reasoning and Cancer Registration from Pathology Reports - Giulio Napolitano, Northern Ireland Cancer Registry, Queens University, Belfast
• Stage distribution and excess mortality rates in breast and colorectal cancer patients diagnosed in N. Ireland (NI) 1993-2007 - Finian Bannon, Northern Ireland Cancer Registry, Queens University, Belfast

Access to medicines

• Chair's introduction - Professor Jane Maher, Chief Medical Officer, Macmillan Cancer Support
• Real World Oncology Evidence and Value Based Pricing (VBP); A unique opportunity for an integrated NHS solution - Gavin Lewis, Roche Products Limited
• Off Protocol Prescribing in Oncology and Haematology within NHS Tayside: an Audit of the NHS Tayside Oncology and Haematology Medicines Management Group - Douglas Dorward, University of Dundee
• The Cancer Drugs Fund - David Thomson, Lead Pharmacist, Yorkshire Cancer Network

Less Common Cancers

Supporting commissioning

• Chair's introduction - Jane Whittome, Associate Director for Hospital Services, National Cancer Action Team
• Levers to support commissioning - Anthony Gore, Primary Care Cancer Lead Clinician, NHS Sheffield
• The specialised commissioning view - Sean Duffy, Chair, Specialised Cancer Clinical Reference Group & Director / Medical Director, Yorkshire Cancer Network
• The cancer network view - Roy McLachlan, Director, North of England Cancer Network

Day two – 15th June

Supporting research

• Chair's introduction - David Ardron, Lay member, National Cancer Intelligence Network Steering Group
• Clinical Practice Research Datalink - John Parkinson, Director, Clinical Practice Research Datalink
• The Secure Anonymised Information Linkage (SAIL) system: challenges and opportunities in health data linkage - Kerina Jones, Senior Research Fellow, Health Information Research Unit (HIRU)
• Research opportunities in UK Biobank - Cathie Sudlow, Chief Scientist, UK Biobank

AM Parallel sessions

Health economics

• Chair's introduction - Dr Linda Sharp, Epidemiologist, National Cancer Registry, Ireland
• A cost-benefit analysis of the National Training Programme in Laparoscopic Colorectal Surgery (Lapco) - Melody Ni, Imperial College London
• Costing Cancer Pathways - cost accumulation over time and variation as a function of survivorship and associated morbidities within a tumour-specific outcomes framework - A Woolmore, Monitor Group
• The economic impact of colorectal cancer: what are the costs and where do they fall? - Paul Hanly, University College, Cork

International focus

Co-morbidity and risk adjustment

PM Parallel sessions

Data visualisation

• Chair's introduction - Dr David Brewster, Director, Scottish Cancer Registry
• Using data visualisation to engage the public and to communicate the messages to cancer research and control - Alan Slater, Cancer Research UK
• What is a Kaplan-Meier Plot anyway? - David Ardron,  Lay member, National Cancer Intelligence Network Steering Group
• Insight Track; a new tool for visualising and following the patient pathway - Sarah Stevens, Eastern Cancer Registration and Information Centre

Primary care

• Chair's introduction - Professor Una Macleod, Professor of Primary Care Medicine, Hull York Medical School
• The risk of childhood cancer with symptoms/signs presenting in primary care in the UK: a population-based case-control study - Mike Stevens, Bristol Royal Hospital for Children
• Relationship between measures of promptness of cancer diagnosis in primary care - Dr Gary Abel, University of Cambridge
• Association between patient and general practice characteristics and unplanned first-time admissions for cancer - Alex Bottle, Imperial College London

Equalities

Future opportunities for national cancer intelligence - The Brian Cottier session

• Chair's introduction - Richard Stephens, Chair, National Cancer Research Institute Consumer Liaison Group
• Less is more! The way forward - Simon Davies, Chair of Cancer52 - representing 53 cancer charities that focus on rare and less common cancers
• National cancer intelligence: where now; where next? - Mike Richards, National Cancer Director for England